PRRT2 and deep vein thrombosis: Moreover, studies show that PKC-θ is activated by GPVI agonists; observing a knockout PKC-θ murine model (model of thrombosis induced with FeCl3) led to a compromised hemostasis, prolonged bleeding time, an unstable formation of thrombi, and extended arterial occlusion [77,78].